These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11589857)

  • 1. Survey of current practices in use of amiodarone and implantable cardioverter defibrillators in pediatric patients with end-stage heart failure.
    Dubin AM; Van Hare GF; Collins KK; Bernstein D; Rosenthal DN
    Am J Cardiol; 2001 Oct; 88(7):809-10. PubMed ID: 11589857
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Dardas and Aaronson regarding article, "Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial".
    Dardas TF; Aaronson KD
    Circulation; 2010 Oct; 122(15):e486; author reply e487. PubMed ID: 20937985
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 5. Life and death after ICD implantation.
    Healey J; Connolly S
    N Engl J Med; 2008 Sep; 359(10):1058-9. PubMed ID: 18768951
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amiodarone or ICD in patients with cardiac insufficiency. SCD-HeFT Study].
    Borggrefe M; Wolpert C
    Internist (Berl); 2006 Jan; 47(1):89-91. PubMed ID: 16344952
    [No Abstract]   [Full Text] [Related]  

  • 8. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
    N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
    Eckardt L; Breithardt G
    Heart Rhythm; 2006 Apr; 3(4):484-7. PubMed ID: 16567301
    [No Abstract]   [Full Text] [Related]  

  • 11. Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race?
    Al-Khatib SM; Sanders GD; O'Brien SM; Matlock D; Zimmer LO; Masoudi FA; Peterson E
    Ann Noninvasive Electrocardiol; 2011 Jan; 16(1):77-84. PubMed ID: 21251138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
    Hsieh YC; Huang JL; Chin CS; Lin TC; Liao YC; Ting CT; Wu TJ
    Europace; 2011 Jan; 13(1):137-9. PubMed ID: 20851824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.
    Mehra MR; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; O'Connor CM; Reynolds D; Walsh MN; Fonarow GC
    Heart Rhythm; 2009 Dec; 6(12):1727-34. PubMed ID: 19959119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrillation testing: the need for a definitive trial.
    Duray GZ; Hohnloser SH
    J Cardiovasc Electrophysiol; 2010 Feb; 21(2):183-5. PubMed ID: 19804540
    [No Abstract]   [Full Text] [Related]  

  • 15. [Congestive heart failure and arrhythmia].
    Kasanuki H
    Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Di Biase L; Mohanty P; Mohanty S; Santangeli P; Trivedi C; Lakkireddy D; Reddy M; Jais P; Themistoclakis S; Dello Russo A; Casella M; Pelargonio G; Narducci ML; Schweikert R; Neuzil P; Sanchez J; Horton R; Beheiry S; Hongo R; Hao S; Rossillo A; Forleo G; Tondo C; Burkhardt JD; Haissaguerre M; Natale A
    Circulation; 2016 Apr; 133(17):1637-44. PubMed ID: 27029350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lethal arrhythmia associated with heart failure].
    Shiga T; Hagiwara N; Kasanuki H
    Nihon Rinsho; 2007 May; 65 Suppl 5():364-8. PubMed ID: 17571407
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiodarone in congestive heart failure: unravelling the GESICA and CHF-STAT differences.
    Hammill SC; Packer DL
    Heart; 1996 Jan; 75(1):6-7. PubMed ID: 8624874
    [No Abstract]   [Full Text] [Related]  

  • 19. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators.
    Patwala A; Schlosshan D; Williams SG
    N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15892193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.